The effects of bright light treatment on affective symptoms in people with dementia: a 24-week cluster randomized controlled trial.

Affective symptoms Behavioral and psychological symptoms of dementia Bright light therapy Clinical trial Dementia Depression Nursing homes

Journal

BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559

Informations de publication

Date de publication:
28 07 2021
Historique:
received: 22 12 2020
accepted: 10 07 2021
entrez: 29 7 2021
pubmed: 30 7 2021
medline: 7 8 2021
Statut: epublish

Résumé

The majority of people with dementia have behavioral and psychological symptoms of dementia (BPSD), including depression, anxiety and agitation. These may be elicited or aggravated by disrupted circadian rhythms. Bright light treatment (BLT) is a promising non-pharmacological approach to the management of BPSD, but previous research has yielded mixed results. Eight nursing home dementia units (1 unit = 1 cluster) with 78 patients were invited to participate in a cluster randomized controlled trial from September 2017 to April 2018 investigating the effects of BLT on sleep and circadian rhythms (primary outcome) and BPSD (secondary outcome). Ceiling mounted LED-panels were installed in the intervention group (four units), providing light at 1000 lx and 6000 K (vertically at 1.2 m) between 10 a.m. and 3 p.m., with lower values in the mornings and evenings. Standard indoor light was used in the control group (four units). BPSD were assessed with The Cornell Scale for Depression in Dementia (CSDD) and the Neuropsychiatric Inventory Nursing Home Version (NPI-NH). Data collection took place at baseline and after 8, 16 and 24 weeks. Multilevel regression models with and without false discovery rate correction were used for the analysis, with baseline values and dementia stage entered as covariates. Sixty-nine patients were included in the study at baseline. Compared to the control group, the intervention group had a larger reduction on the composite scores of both the CSDD (95% CI = - 6.0 - - 0.3) and the NPI-NH (95% CI = - 2.2 - - 0.1), as well as on the NPI-NH Affect sub-syndrome, and the CSDD Mood related signs sub-scale at follow-up after 16 weeks. With FDR correction, the group difference was significant on the CSDD Mood related signs sub-scale (95% CI = - 2.7 - - 0.8) and the NPI-NH Affect sub-syndrome (95% CI = - 1.6 - - 0.2). No differences were found between conditions at weeks 8 or 24. Compared to the control condition, affective symptoms were reduced after 16 weeks in the group receiving BLT, suggesting BLT may be beneficial for nursing home patients with dementia. ClinicalTrials.gov Identifier: NCT03357328 . Retrospectively registered on November 29, 2017.

Sections du résumé

BACKGROUND
The majority of people with dementia have behavioral and psychological symptoms of dementia (BPSD), including depression, anxiety and agitation. These may be elicited or aggravated by disrupted circadian rhythms. Bright light treatment (BLT) is a promising non-pharmacological approach to the management of BPSD, but previous research has yielded mixed results.
METHODS
Eight nursing home dementia units (1 unit = 1 cluster) with 78 patients were invited to participate in a cluster randomized controlled trial from September 2017 to April 2018 investigating the effects of BLT on sleep and circadian rhythms (primary outcome) and BPSD (secondary outcome). Ceiling mounted LED-panels were installed in the intervention group (four units), providing light at 1000 lx and 6000 K (vertically at 1.2 m) between 10 a.m. and 3 p.m., with lower values in the mornings and evenings. Standard indoor light was used in the control group (four units). BPSD were assessed with The Cornell Scale for Depression in Dementia (CSDD) and the Neuropsychiatric Inventory Nursing Home Version (NPI-NH). Data collection took place at baseline and after 8, 16 and 24 weeks. Multilevel regression models with and without false discovery rate correction were used for the analysis, with baseline values and dementia stage entered as covariates.
RESULTS
Sixty-nine patients were included in the study at baseline. Compared to the control group, the intervention group had a larger reduction on the composite scores of both the CSDD (95% CI = - 6.0 - - 0.3) and the NPI-NH (95% CI = - 2.2 - - 0.1), as well as on the NPI-NH Affect sub-syndrome, and the CSDD Mood related signs sub-scale at follow-up after 16 weeks. With FDR correction, the group difference was significant on the CSDD Mood related signs sub-scale (95% CI = - 2.7 - - 0.8) and the NPI-NH Affect sub-syndrome (95% CI = - 1.6 - - 0.2). No differences were found between conditions at weeks 8 or 24.
CONCLUSION
Compared to the control condition, affective symptoms were reduced after 16 weeks in the group receiving BLT, suggesting BLT may be beneficial for nursing home patients with dementia.
TRIAL REGISTRATION
ClinicalTrials.gov Identifier: NCT03357328 . Retrospectively registered on November 29, 2017.

Identifiants

pubmed: 34320937
doi: 10.1186/s12888-021-03376-y
pii: 10.1186/s12888-021-03376-y
pmc: PMC8317398
doi:

Banques de données

ClinicalTrials.gov
['NCT03357328']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

377

Informations de copyright

© 2021. The Author(s).

Références

J Opt Soc Am A Opt Image Sci Vis. 2016 Jun 1;33(6):1049-59
pubmed: 27409431
Front Neurol. 2017 May 04;8:162
pubmed: 28522986
Eur Neuropsychopharmacol. 2008 Oct;18(10):701-11
pubmed: 18662865
Psychiatry Clin Neurosci. 2004 Aug;58(4):343-7
pubmed: 15298644
Int Psychogeriatr. 2012 Jan;24(1):62-73
pubmed: 21682940
PLoS One. 2011 Jan 26;6(1):e16429
pubmed: 21298068
Sleep Med Clin. 2009 Jun;4(2):165-177
pubmed: 20161220
J Affect Disord. 2018 May;232:291-299
pubmed: 29500957
Dement Geriatr Cogn Disord. 2010;29(5):438-47
pubmed: 20502018
Einstein J Biol Med. 2017;32:E13-E25
pubmed: 31528147
Issues Ment Health Nurs. 2018 May;39(5):370-373
pubmed: 29509051
Curr Alzheimer Res. 2017;14(10):1063-1075
pubmed: 28545364
Arch Gen Psychiatry. 2001 Jan;58(1):69-75
pubmed: 11146760
Curr Biol. 2006 Aug 22;16(16):1616-21
pubmed: 16920622
Am J Clin Nutr. 2015 Oct;102(4):721-8
pubmed: 26245806
Behav Res Methods. 2009 Nov;41(4):1149-60
pubmed: 19897823
Sleep Med Rev. 2007 Dec;11(6):485-96
pubmed: 17964201
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Nat Rev Neurosci. 2018 Aug;19(8):453-469
pubmed: 29934559
Ann N Y Acad Sci. 2010 Apr;1193:48-59
pubmed: 20398008
Nat Rev Neurosci. 2014 Jul;15(7):443-54
pubmed: 24917305
JAMA. 2008 Jun 11;299(22):2642-55
pubmed: 18544724
Dialogues Clin Neurosci. 2003 Dec;5(4):389-98
pubmed: 22033639
J Am Geriatr Soc. 2017 Oct;65(10):2227-2234
pubmed: 28734045
J Neurol Neurosurg Psychiatry. 2015 Jan;86(1):101-9
pubmed: 24876182
Biol Psychiatry. 1988 Feb 1;23(3):271-84
pubmed: 3337862
JAMA. 2005 Oct 19;294(15):1934-43
pubmed: 16234500
Dement Geriatr Cogn Disord. 2018;46(5-6):371-384
pubmed: 30537760
Chronobiol Int. 2019 Feb;36(2):151-170
pubmed: 30311830
BMC Med. 2010 Mar 24;8:18
pubmed: 20334633
Front Psychiatry. 2019 Mar 01;10:85
pubmed: 30881318
Int Psychogeriatr. 1992;4 Suppl 1:55-69
pubmed: 1504288
Int J Geriatr Psychiatry. 2013 Aug;28(8):868-76
pubmed: 23147389
Int J Geriatr Psychiatry. 2002 May;17(5):403-8
pubmed: 11994927
Sleep Med Rev. 2013 Dec;17(6):475-88
pubmed: 23669093
Sleep Med Rev. 2016 Oct;29:52-62
pubmed: 26606319
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
J Am Geriatr Soc. 2014 Apr;62(4):762-9
pubmed: 24635665
Br J Ophthalmol. 2008 Nov;92(11):1439-44
pubmed: 18757473
Psychopharmacol Bull. 1988;24(4):653-9
pubmed: 3249767
BMC Geriatr. 2021 May 17;21(1):312
pubmed: 34001024
J Sleep Res. 2003 Dec;12(4):331-7
pubmed: 14633245
Sleep Med. 2019 Sep;61:6-18
pubmed: 31262550
J Affect Disord. 2015 Aug 15;182:1-7
pubmed: 25942575
Sleep Med Rev. 2020 Aug;52:101310
pubmed: 32289734
Sleep Med Clin. 2015 Dec;10(4):469-80
pubmed: 26568123
Lancet. 2011 Jul 30;378(9789):403-11
pubmed: 21764118
Curr Alzheimer Res. 2017;14(10):1076-1083
pubmed: 28595522
Int Psychogeriatr. 2008 Apr;20(2):375-82
pubmed: 17559707
Clin Interv Aging. 2014 Sep 12;9:1527-37
pubmed: 25246779
Am J Psychiatry. 2005 Apr;162(4):656-62
pubmed: 15800134
BMJ. 2015 Mar 02;350:h369
pubmed: 25731881
Int J Geriatr Psychiatry. 2010 Oct;25(10):1013-21
pubmed: 20104513
J Affect Disord. 2008 May;108(1-2):11-23
pubmed: 17950467
Neurology. 1994 Dec;44(12):2308-14
pubmed: 7991117
J Am Geriatr Soc. 2007 Nov;55(11):1817-24
pubmed: 17944896
Cell. 2018 Sep 20;175(1):71-84.e18
pubmed: 30173913
Cochrane Database Syst Rev. 2014 Feb 26;(2):CD003946
pubmed: 24574061
Issues Ment Health Nurs. 2016 Sep;37(9):660-667
pubmed: 27254531
J Am Geriatr Soc. 1992 Sep;40(9):922-35
pubmed: 1512391
Sleep Med Rev. 2018 Dec;42:47-58
pubmed: 30404728
Curr Biol. 2016 May 23;26(10):R432-43
pubmed: 27218855
Science. 1999 Jun 25;284(5423):2177-81
pubmed: 10381883

Auteurs

Eirin Kolberg (E)

Department of Clinical Psychology, Faculty of Psychology, University of Bergen (UiB), Aarstadveien 17, 5009, Bergen, Norway. Eirin.Kolberg@uib.no.

Gunnhild Johnsen Hjetland (GJ)

Department of Clinical Psychology, Faculty of Psychology, University of Bergen (UiB), Aarstadveien 17, 5009, Bergen, Norway.
City Department of Health and Care, City of Bergen, Norway.

Eirunn Thun (E)

Department of Clinical Psychology, Faculty of Psychology, University of Bergen (UiB), Aarstadveien 17, 5009, Bergen, Norway.

Ståle Pallesen (S)

Department of Psychosocial Science, Faculty of Psychology, University of Bergen (UiB) Christies gate 12, 5015 Bergen, Bergen, Norway.
Norwegian Competence Center for Sleep Disorders, Haukeland University Hospital, Bergen, Norway.
Optentia, the Vaal Triangle Campus of the North-West University, Vanderbijlpark, South Africa.

Inger Hilde Nordhus (IH)

Department of Clinical Psychology, Faculty of Psychology, University of Bergen (UiB), Aarstadveien 17, 5009, Bergen, Norway.
Department of Behavioral Medicine, Faculty of Medicine, University of Oslo, (UiO), Oslo, Norway.

Bettina S Husebo (BS)

Centre for Elderly and Nursing Home Medicine (SEFAS), Department of Global Public Health and Primary Care, University of Bergen (UiB), Aarstadveien 17, 5009, Bergen, Norway.

Elisabeth Flo-Groeneboom (E)

Department of Clinical Psychology, Faculty of Psychology, University of Bergen (UiB), Aarstadveien 17, 5009, Bergen, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH